Histopathological characterization of a syngeneic orthotopic murine bladder cancer model

PURPOSE: We developed and characterized by histopathology and immunohistochemistry a syngeneic murine bladder tumor model derived from the MB49 tumor cell line. MATERIALS AND METHODS: Bladder tumor implantation was achieved by intravesical instillation of 5 x 10(5) MB49 tumor cells in C57BL/6 mice. A chemical lesion of the bladder was performed in order to promote intravesical tumor implantation. The bladder wall lesion was accomplished by transurethral instillation of silver nitrate (AgNO3). After 15 days, the animals were sacrificed, examined macroscopically for intravesical tumor and bladder weight. Histology and immunohistochemistry were performed using cytokeratin 7 (CK7), carcinoembrionic antigen (Dako-CEA), p53 and c-erbB2 oncoprotein (Her2/neu). RESULTS: Twenty-nine out of 30 animals (96.7%) developed intravesical tumors in a 15-day period. Macroscopically, the mean bladder weight was 0.196g (0.069-0.538g), 10 to 15 times the normal bladder weight. The immunohistochemical analysis showed significant membrane expression of CEA and CK7: a similar finding for human urothelial cancer. We also characterized absence of expression of p53 and anti-Her2/neu in the murine model. CONCLUSIONS: High tumor take rates were achieved by using the chemical induction of the bladder tumor. Although electric cauterization is widely described in the literature for syngeneic orthotopic animal models, the technique described in this study represents an alternative for intravesical bladder tumor implantation. Moreover, the histopathology and immunohistochemical analysis of the murine bladder tumor model derived from the MB49 cell line showed a resemblance to human infiltrating urothelial carcinoma, allowing clinical inference from experimental immunotherapy testing.

Saved in:
Bibliographic Details
Main Authors: Chade,Daher C., Andrade,Priscila M., Borra,Ricardo C., Leite,Katia R., Andrade,Enrico, Villanova,Fabiola E., Srougi,Miguel
Format: Digital revista
Language:English
Published: Sociedade Brasileira de Urologia 2008
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382008000200013
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S1677-55382008000200013
record_format ojs
spelling oai:scielo:S1677-553820080002000132008-10-06Histopathological characterization of a syngeneic orthotopic murine bladder cancer modelChade,Daher C.Andrade,Priscila M.Borra,Ricardo C.Leite,Katia R.Andrade,EnricoVillanova,Fabiola E.Srougi,Miguel bladder cancer intravesical instillation tumor cell line mice/c57bl experimental neoplasm PURPOSE: We developed and characterized by histopathology and immunohistochemistry a syngeneic murine bladder tumor model derived from the MB49 tumor cell line. MATERIALS AND METHODS: Bladder tumor implantation was achieved by intravesical instillation of 5 x 10(5) MB49 tumor cells in C57BL/6 mice. A chemical lesion of the bladder was performed in order to promote intravesical tumor implantation. The bladder wall lesion was accomplished by transurethral instillation of silver nitrate (AgNO3). After 15 days, the animals were sacrificed, examined macroscopically for intravesical tumor and bladder weight. Histology and immunohistochemistry were performed using cytokeratin 7 (CK7), carcinoembrionic antigen (Dako-CEA), p53 and c-erbB2 oncoprotein (Her2/neu). RESULTS: Twenty-nine out of 30 animals (96.7%) developed intravesical tumors in a 15-day period. Macroscopically, the mean bladder weight was 0.196g (0.069-0.538g), 10 to 15 times the normal bladder weight. The immunohistochemical analysis showed significant membrane expression of CEA and CK7: a similar finding for human urothelial cancer. We also characterized absence of expression of p53 and anti-Her2/neu in the murine model. CONCLUSIONS: High tumor take rates were achieved by using the chemical induction of the bladder tumor. Although electric cauterization is widely described in the literature for syngeneic orthotopic animal models, the technique described in this study represents an alternative for intravesical bladder tumor implantation. Moreover, the histopathology and immunohistochemical analysis of the murine bladder tumor model derived from the MB49 cell line showed a resemblance to human infiltrating urothelial carcinoma, allowing clinical inference from experimental immunotherapy testing.info:eu-repo/semantics/openAccessSociedade Brasileira de UrologiaInternational braz j urol v.34 n.2 20082008-03-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382008000200013en10.1590/S1677-55382008000200013
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Chade,Daher C.
Andrade,Priscila M.
Borra,Ricardo C.
Leite,Katia R.
Andrade,Enrico
Villanova,Fabiola E.
Srougi,Miguel
spellingShingle Chade,Daher C.
Andrade,Priscila M.
Borra,Ricardo C.
Leite,Katia R.
Andrade,Enrico
Villanova,Fabiola E.
Srougi,Miguel
Histopathological characterization of a syngeneic orthotopic murine bladder cancer model
author_facet Chade,Daher C.
Andrade,Priscila M.
Borra,Ricardo C.
Leite,Katia R.
Andrade,Enrico
Villanova,Fabiola E.
Srougi,Miguel
author_sort Chade,Daher C.
title Histopathological characterization of a syngeneic orthotopic murine bladder cancer model
title_short Histopathological characterization of a syngeneic orthotopic murine bladder cancer model
title_full Histopathological characterization of a syngeneic orthotopic murine bladder cancer model
title_fullStr Histopathological characterization of a syngeneic orthotopic murine bladder cancer model
title_full_unstemmed Histopathological characterization of a syngeneic orthotopic murine bladder cancer model
title_sort histopathological characterization of a syngeneic orthotopic murine bladder cancer model
description PURPOSE: We developed and characterized by histopathology and immunohistochemistry a syngeneic murine bladder tumor model derived from the MB49 tumor cell line. MATERIALS AND METHODS: Bladder tumor implantation was achieved by intravesical instillation of 5 x 10(5) MB49 tumor cells in C57BL/6 mice. A chemical lesion of the bladder was performed in order to promote intravesical tumor implantation. The bladder wall lesion was accomplished by transurethral instillation of silver nitrate (AgNO3). After 15 days, the animals were sacrificed, examined macroscopically for intravesical tumor and bladder weight. Histology and immunohistochemistry were performed using cytokeratin 7 (CK7), carcinoembrionic antigen (Dako-CEA), p53 and c-erbB2 oncoprotein (Her2/neu). RESULTS: Twenty-nine out of 30 animals (96.7%) developed intravesical tumors in a 15-day period. Macroscopically, the mean bladder weight was 0.196g (0.069-0.538g), 10 to 15 times the normal bladder weight. The immunohistochemical analysis showed significant membrane expression of CEA and CK7: a similar finding for human urothelial cancer. We also characterized absence of expression of p53 and anti-Her2/neu in the murine model. CONCLUSIONS: High tumor take rates were achieved by using the chemical induction of the bladder tumor. Although electric cauterization is widely described in the literature for syngeneic orthotopic animal models, the technique described in this study represents an alternative for intravesical bladder tumor implantation. Moreover, the histopathology and immunohistochemical analysis of the murine bladder tumor model derived from the MB49 cell line showed a resemblance to human infiltrating urothelial carcinoma, allowing clinical inference from experimental immunotherapy testing.
publisher Sociedade Brasileira de Urologia
publishDate 2008
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382008000200013
work_keys_str_mv AT chadedaherc histopathologicalcharacterizationofasyngeneicorthotopicmurinebladdercancermodel
AT andradepriscilam histopathologicalcharacterizationofasyngeneicorthotopicmurinebladdercancermodel
AT borraricardoc histopathologicalcharacterizationofasyngeneicorthotopicmurinebladdercancermodel
AT leitekatiar histopathologicalcharacterizationofasyngeneicorthotopicmurinebladdercancermodel
AT andradeenrico histopathologicalcharacterizationofasyngeneicorthotopicmurinebladdercancermodel
AT villanovafabiolae histopathologicalcharacterizationofasyngeneicorthotopicmurinebladdercancermodel
AT srougimiguel histopathologicalcharacterizationofasyngeneicorthotopicmurinebladdercancermodel
_version_ 1756428021873508352